Stapo 15 MIU Injection

Prezentare produs

About Stapo 15 MIU Injection

Stapo 15 MIU Injection is a medication containing the active ingredient Streptokinase, classified as Pharmaceutical drug. Streptokinase is a thrombolytic medication activating plasminogen by nonenzymatic mechanism. As a medication it is used to break down clots in some cases of myocardial infarction, pulmonary embolism, and arterial thromboembolism. The type of heart attack it is used in is an ST elevation myocardial infarction (STEMI).

Key Benefits & Uses

• Used for: Streptokinase is a thrombolytic medication activating plasminogen by nonenzymatic mechanism
• Used for: As a medication it is used to break down clots in some cases of myocardial infarction, pulmonary embolism, and arterial thromboembolism
• Used for: The type of heart attack it is used in is an ST elevation myocardial infarction (STEMI)

Active Ingredient & Action

Streptokinase, the active ingredient in Stapo 15 MIU Injection, belongs to the Pharmaceutical drug class. Its clinical use follows the authorised labelling for Streptokinase-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Stapo 15 MIU Injection. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Stapo 15 MIU Injection for extended periods without medical advice.